Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease
- PMID: 9033543
- DOI: 10.4065/72.2.117
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease
Abstract
Objective: To explore the potential role of eosinophils in the pathogenesis of inflammatory bowel disease (IBD).
Design: We measured the concentrations of eosinophil granule proteins-namely, major basic protein, eosinophil peroxidase, eosinophil cationic protein, and eosinophil-derived neurotoxin-in gut lavage fluid.
Material and methods: Ten healthy persons and 17 patients with IBD (9 with Crohn's disease and 8 with ulcerative colitis) underwent gut lavage. Each study subject submitted an early specimen when lavage effluent became liquid and a late specimen when the output became clear. The concentrations of the granule proteins were measured by immunoassay.
Results: The median concentrations of eosinophil-derived neurotoxin and eosinophil cationic protein were significantly higher in patients with IBD than in control subjects for both early and late lavage specimens. Excretion of eosinophil peroxidase was also significantly higher in patients with IBD than in the healthy control subjects, but only in the early specimens. No differences were noted in the concentrations of any of the proteins between patients with ulcerative colitis and those with Crohn's disease.
Conclusion: Concentrations of eosinophil granule proteins were increased in whole gut lavage fluid from patients with IBD in comparison with healthy control subjects. These results encourage further studies of the role of eosinophils in the pathogenesis of IBD.
Similar articles
-
Increased concentrations of eosinophilic cationic protein in whole-gut lavage fluid from children with inflammatory bowel disease.J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):164-8. doi: 10.1097/00005176-199902000-00014. J Pediatr Gastroenterol Nutr. 1999. PMID: 9932849
-
Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.Am J Gastroenterol. 1999 Dec;94(12):3513-20. doi: 10.1111/j.1572-0241.1999.01640.x. Am J Gastroenterol. 1999. PMID: 10606313
-
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.Am J Gastroenterol. 1999 Jul;94(7):1876-83. doi: 10.1111/j.1572-0241.1999.01223.x. Am J Gastroenterol. 1999. PMID: 10406252
-
The molecular biology of eosinophil granule proteins.Int Arch Allergy Appl Immunol. 1991;94(1-4):202-9. doi: 10.1159/000235362. Int Arch Allergy Appl Immunol. 1991. PMID: 1657792 Review.
-
[Biochemistry and biological activities of eosinophil granule proteins].Nihon Rinsho. 1993 Mar;51(3):605-12. Nihon Rinsho. 1993. PMID: 7684096 Review. Japanese.
Cited by
-
Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.Am J Gastroenterol. 2010 Feb;105(2):298-307. doi: 10.1038/ajg.2009.584. Epub 2009 Nov 3. Am J Gastroenterol. 2010. PMID: 19888203 Free PMC article.
-
Rectal effluent as a research tool.Dig Dis Sci. 2015 Jan;60(1):24-31. doi: 10.1007/s10620-014-3330-0. Epub 2014 Sep 2. Dig Dis Sci. 2015. PMID: 25179492 Review.
-
Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.Clin Exp Immunol. 2000 Oct;122(1):35-40. doi: 10.1046/j.1365-2249.2000.01337.x. Clin Exp Immunol. 2000. PMID: 11012615 Free PMC article.
-
Eosinophilic colitis in children.Postepy Dermatol Alergol. 2017 Feb;34(1):52-59. doi: 10.5114/ada.2017.65622. Epub 2017 Feb 7. Postepy Dermatol Alergol. 2017. PMID: 28261032 Free PMC article.
-
Eosinophilic esophagitis: an emerging clinicopathologic entity.Curr Allergy Asthma Rep. 2002 Jan;2(1):67-72. doi: 10.1007/s11882-002-0042-x. Curr Allergy Asthma Rep. 2002. PMID: 11895629 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources